Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Germinal center kinases (GCKs) are a large subfamily of serine/threonine kinases in the STE20 family, highly conserved across eukaryotes and widely expressed in mammalian tissues. They are critical regulators of multiple cellular processes, including signal transduction, apoptosis, immune response, cell cycle progression, cell proliferation, migration, and cytoskeletal dynamics. GCKs participate in key signaling pathways involving MAP kinases (ERK, JNK, p38), influence both innate and adaptive immunity, and play context-dependent roles in health and disease, particularly in cancer, autoimmune disease, and inflammation. Members of the family include multiple kinases with diverse but overlapping functions, such as GLK (MAP4K3), TNIK, STK24, STK25, and others. The term "germinal center kinase" lacks specificity and should be mapped to the appropriate kinase (e.g., GLK/MAP4K3) for research or therapeutic purposes.
Inhibition of kinase activity leads to modulation of immune signaling, decreased T-cell activation, reduced pro-inflammatory cytokine production, and altered cell proliferation/apoptosis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Germinal center kinase (family) (GCK).